Overview

Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis

Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to compare the effectiveness of commonly used immunosuppressant treatments for early diffuse cutaneous systemic sclerosis (SSc).
Details
Lead Sponsor:
University of Manchester
Treatments:
Cyclophosphamide
Immunosuppressive Agents
Methotrexate
Mycophenolate mofetil
Mycophenolic Acid